Table 1.
Basic Clinical Characteristics of the Study Population (n = 96).
| Variables | Patients, N (%) |
|---|---|
| Gender | |
| Female | 15(15.63) |
| Male | 81(84.37) |
| Age (years) | |
| ≤40 | 15(15.63) |
| 41–50 | 22(22.92) |
| 51–60 | 36(37.5) |
| 61–70 | 19(19.79) |
| >70 | 4(4.16) |
| ALT (U/L) | |
| ≤40 | 58(60.42) |
| >40 | 37(30.58) |
| AST(U/L) | |
| ≤40 | 55(57.29) |
| >40 | 41(42.71) |
| ALB/GLB | |
| >2.5 | 2(2.08) |
| 1.0–2.5 | 91(94.79) |
| <1.0 | 3(3.13) |
| Total bilirubin(μmol/L) | |
| ≤17 | 67(69.79) |
| >17 | 29(30.21) |
| HBeAg | |
| (+) | 17(17.71) |
| (–) | 75(78.13) |
| None | 4(4.17) |
| HBV DNA | |
| <104 | 37(38.54) |
| 104–106 | 29(30.21) |
| ≥106 | 18(18.75) |
| None | 12(12.5) |
| Platelets (109/L) | |
| Median (IQR) | 181.5(148.75–181.5) |
| White blood cells (109/L) | |
| Median (IQR) | 6.01(4.74–8.14) |
| NEUT% | 59.00(50.50–68.25) |
| MO% | 8.00(7.00–10.00) |
| LYM% | 29.00(19.75–36.25) |
| Fibrosis | |
| F0-1(Mild) | 21(21.88) |
| F2-3 (Moderate) | 34(35.41) |
| F4(Severe/cirrhosis) | 41(42.71) |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALB, albumin; GLB, globulin.